NASDAQ:ISPC iSpecimen (ISPC) Stock Price, News & Analysis $0.46 -0.07 (-13.58%) Closing price 11/20/2026 04:00 PM EasternExtended Trading$0.47 +0.02 (+3.44%) As of 11/20/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsNews and TrendsSEC Filings About iSpecimen Stock (NASDAQ:ISPC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get iSpecimen alerts:Sign Up Key Stats Today's Range$0.43▼$0.5350-Day Range$0.46▼$1.4752-Week Range$0.43▼$27.44Volume150,786 shsAverage Volume280,052 shsMarket Capitalization$1.15 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview iSpecimen, Inc. operates an online marketplace that connects life-science researchers with hospitals, laboratories, biobanks and other providers of human biospecimens. Its platform is designed to help researchers find and request samples for medical and scientific research. Through its iSpecimen Marketplace, the company facilitates access to materials such as blood, tissue and other human specimens, along with associated data when available. It also supports the coordination of specimen sourcing and fulfillment between research organizations and providers. Founded in 2009 by Christopher Ianelli, iSpecimen has built a network intended to serve research organizations and specimen providers in the United States and internationally.AI Generated. May Contain Errors. Read More iSpecimen Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreISPC MarketRank™: 0.28685650161 of 5 starsiSpecimen scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingiSpecimen has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageiSpecimen has only been the subject of 1 research reports in the past 90 days.Read more about iSpecimen's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of iSpecimen is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iSpecimen is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiSpecimen has a P/B Ratio of 0.28. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.80% of the float of iSpecimen has been sold short.Short Interest Ratio / Days to CoveriSpecimen has a short interest ratio ("days to cover") of 0.74, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in iSpecimen has recently increased by 92.25%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiSpecimen does not currently pay a dividend.Dividend GrowthiSpecimen does not have a long track record of dividend growth. News and Social Media1.5 / 5News Sentiment-0.67 News SentimentiSpecimen has a news sentiment score of -0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for iSpecimen this week, compared to 1 article on an average week.MarketBeat Follows1 people have added iSpecimen to their MarketBeat watchlist in the last 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, iSpecimen insiders have not sold or bought any company stock.Percentage Held by Insiders12.20% of the stock of iSpecimen is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions13.62% of the stock of iSpecimen is held by institutions.Read more about iSpecimen's insider trading history. Receive ISPC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ISPC Stock News HeadlinesiSpecimen (NASDAQ:ISPC) Stock to Reverse Split on Tuesday, November 24thNovember 20 at 2:00 AM | americanbankingnews.comiSpecimen Reports Delay in Its Quarterly FilingNovember 17, 2026 | tipranks.comWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.November 22 at 1:00 AM | Porter & Company (Ad)iSpecimen Shareholders Approve Key Financing and Acquisition ActionsOctober 9, 2026 | tipranks.comISpecimen In Focus, Genelux Nears Phase 3 Ovarian Cancer Data, Biofrontera Awaits FDA DecisionSeptember 8, 2026 | rttnews.comiSpecimen to Acquire Foldlab AI Disease AnalyticsSeptember 4, 2026 | tipranks.comiSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three WeeksAugust 20, 2026 | globenewswire.comiSpecimen Engages IR Agency for Investor MarketingAugust 14, 2026 | tipranks.comSee More Headlines ISPC Stock Analysis - Frequently Asked Questions How have ISPC shares performed this year? iSpecimen's stock was trading at $10.4040 at the start of the year. Since then, ISPC stock has decreased by 95.6% and is now trading at $0.4563. How were iSpecimen's earnings last quarter? iSpecimen Inc. (NASDAQ:ISPC) released its earnings results on Tuesday, November, 17th. The company reported ($1.03) EPS for the quarter. The company earned $244.03 thousand during the quarter. iSpecimen had a negative trailing twelve-month return on equity of 447.19% and a negative net margin of 1,796.52%. When did iSpecimen's stock split? iSpecimen's stock reverse split on Tuesday, November 24th 2026.A 1-6 reverse split was announced. The number of shares owned by shareholders will be adjusted after the market closes on Monday, November 23rd 2026. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. When did iSpecimen IPO? iSpecimen (ISPC) raised $20 million in an IPO on Tuesday, June 15th 2021. The company issued 2,250,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO. How do I buy shares of iSpecimen? Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iSpecimen own? Based on aggregate information from My MarketBeat watchlists, some other companies that iSpecimen investors own include Advanced Micro Devices (AMD), NIO (NIO), Biofrontera (BFRI), NVIDIA (NVDA), Palantir Technologies (PLTR), Longeveron (LGVN) and AST SpaceMobile (ASTS). Company Calendar Last Earnings11/17/2026Today11/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (10m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 ISPC's financial health is in the Red zone, according to TradeSmith. ISPC has been in this zone for over 10 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:ISPC CIK1558569 Webispecimen.com Phone781-301-6700FaxN/AEmployees7Year FoundedN/AProfitability EPS (Trailing Twelve Months)($38.27) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.49 million Net Margins-1,796.52% Pretax Margin-1,796.69% Return on Equity-447.19% Return on Assets-130.60% Debt Debt-to-Equity RatioN/A Current Ratio1.16 Quick Ratio0.82 Sales & Book Value Annual Sales$466.30 thousand Price / Sales2.46 Cash FlowN/A Price / Cash FlowN/A Book Value$1.62 per share Price / Book0.28Miscellaneous Outstanding Shares2,519,000Free Float2,212,000Market Cap$1.15 million OptionableNot Optionable Beta1.54 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:ISPC) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersPrediction: NVDA will “snap back” on this dateOthers paid $500 for the Snapback Indicator. For Black Friday, Base Camp Trading is offering lifetime access f...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredA quick test most investors failCan you defend your biggest holding? Seeking Alpha Premium gives you its Quant valuation grade versus its sect...Seeking Alpha | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iSpecimen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iSpecimen With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.